Cardiac troponin after percutaneous coronary intervention and 1-year mortality in Non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends

Journal of the American College of Cardiology

Volumn 62, Issue 3, 2013, Pages 242-251

  Tricoci, Pierluigi ^a   Leonardi, Sergio ^b   White, Jennifer ^a   White, Harvey D ^c   Armstrong, Paul W ^d   Montalescot, Gilles ^e   Giugliano, Robert P ^f   Gibson, C Michael ^g   Van De Werf, Frans ^h   Califf, Robert M ^a   Harrington, Robert A ⁱ   Braunwald, Eugene ^f   Mahaffey, Kenneth W ^a   Newby, L Kristin ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c Green Lane Cardiovascular Service ^*  (New Zealand)

^d UNIVERSITY OF ALBERTA   (Canada)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^h UNIVERSITY OF LEUVEN   (Belgium)

ⁱ STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

acute coronary syndrome(s); mortality; myocardial infarction; percutaneous coronary intervention; troponin

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE MB; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; TROPONIN C;

ADULT; AGED; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURGICAL MORTALITY; SURVIVAL TIME; TREND STUDY;

EID: 84880068529     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.04.043     Document Type: Article

References (22)

1. S.D. Wiviott, E. Braunwald, C.H. McCabe TRITON-TIMI 38 Investigators Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
2. P. Tricoci, Z. Huang, C. Held TRACER Investigators Thrombin-receptor antagonist vorapaxar in acute coronary syndromes N Engl J Med 366 2011 20 33
3. K. Thygesen, J.S. Alpert, and A.S. Jaffe Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction Third universal definition of myocardial infarction Eur Heart J 33 2012 2551 2567
4. M.T. Roe, K.W. Mahaffey, and R. Kilaru Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes Eur Heart J 25 2004 313 321
5. T.Q. Kong, C.J. Davidson, S.N. Meyers, J.T. Tauke, M.A. Parker, and R.O. Bonow Prognostic implication of creatine kinase elevation following elective coronary artery interventions JAMA 277 1997 461 466
6. C. Cavallini, S. Savonitto, R. Violini Italian Atherosclerosis, Thrombosis, and Vascular Biology and Society for Invasive Cardiology-GISE Investigators Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study Eur Heart J 26 2005 1494 1498
7. D.A. Morrow, C.P. Cannon, and R.L. Jesse National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes Circulation 115 2007 e356 e375
8. A. Prasad, and J. Herrmann Myocardial infarction due to percutaneous coronary intervention N Engl J Med 364 2011 453 464
9. W.L. Miller, K.N. Garratt, M.F. Burritt, G.S. Reeder, and A.S. Jaffe Timing of peak troponin T and creatine kinase-MB elevations after percutaneous coronary intervention Chest 125 2004 275 280
10. R.P. Giugliano, J.A. White, C. Bode EARLY ACS Investigators Early versus delayed, provisional eptifibatide in acute coronary syndromes N Engl J Med 360 2009 2176 2190
11. J.J. Ferguson, R.M. Califf, and E.M. Antman SYNERGY randomized trial Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial JAMA 292 2004 45 54
12. K.M. Akkerhuis, J.H. Alexander, and B.E. Tardiff Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different? Circulation 105 2002 554 556
13. S.C. Smith Jr., T.E. Feldman, and J.W. Hirshfeld Jr. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention) J Am Coll Cardiol 47 2006 e1 e121
14. J.B. Selvanayagam, I. Porto, and K. Channon Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging Circulation 111 2005 1027 1032
15. L. Testa, R.A. Latini, P. Agostoni, A.P. Banning, and F. Bedogni Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native artery Am J Cardiol 103 2009 1622 1623
16. W.J. Cantor, L.K. Newby, R.H. Christenson SYMPHONY and 2nd SYMPHONY Cardiac Markers Substudy Investigators Prognostic significance of elevated troponin I after percutaneous coronary intervention J Am Coll Cardiol 39 2002 1738 1744
17. J.R. Kizer, M.R. Muttrej, and W.H. Matthai Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention Eur Heart J 24 2003 1314 1322
18. M.K. Natarajan, C. Kreatsoulas, J.L. Velianou, S.R. Mehta, D. Pericak, and D.M. Goodhart Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions Am J Cardiol 93 2004 750 753
19. I.M. Shugman, P. Diu, and J. Gohil Evaluation of troponin T criteria for periprocedural myocardial infarction in patients with acute coronary syndromes Am J Cardiol 107 2011 863 870
20. W.L. Miller, K.N. Garratt, M.F. Burritt, R.J. Lennon, G.S. Reeder, and A.S. Jaffe Baseline troponin level: key to understanding the importance of post-PCI troponin elevations Eur Heart J 27 2006 1061 1069
21. L. Wallentin, R.C. Becker, A. Budaj PLATO Investigators Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
22. V. Novack, M. Pencina, and D.J. Cohen Troponin criteria for myocardial infarction after percutaneous coronary intervention Arch Intern Med 172 2012 502 508